The development of pancreatic most cancers is dependent on many oncogenic modifications. Kras is definitely the most frequently mutated gene (G12D allele) in pancreatic most cancers and it is located in 95% of pancreatic cancers26. While genetically engineered mouse (GEM) versions have convincingly demonstrated that constitutive activation of Kras